Learn about BYETTA, the BYETTA Pen. in patients with prior severe hypersensitivity reactions to exenatide or to any of the product components. Patient Information Leaflet. Package leaflet: Information for the patient. Byetta 5 micrograms solution for injection in pre-filled pen. Byetta 10 micrograms solution . Easy to read FDA package insert, drug facts, dosage and administration, and adverse effects for Byetta (Exenatide).

Author: Mikagul Zolonris
Country: India
Language: English (Spanish)
Genre: Marketing
Published (Last): 22 September 2006
Pages: 288
PDF File Size: 17.4 Mb
ePub File Size: 8.41 Mb
ISBN: 357-8-74919-382-8
Downloads: 59682
Price: Free* [*Free Regsitration Required]
Uploader: Mezishicage

FDA Internet Application Site (Accessdata) Error

Write your html here Increased risk of hypoglycemia when used in combination with a sulfonylurea SU or when used with a glucose-independent insulin secretagogues eg, meglitinides. After initiation and dose increases of BYETTA, observe patients carefully for pancreatitis including persistent severe abdominal pain, sometimes radiating to the back, with or without vomiting. Concurrent use with prandial insulin has not been studied and cannot be recommended.

Symptoms of a severe allergic reaction include severe rash or itching, pwckage of your face, lips, and throat that may cause difficulty breathing or swallowing, feeling faint or ppackage and very rapid heartbeat. The most common side effects with BYETTA include nausea, vomiting, diarrhea, feeling jittery, dizziness, headache, acid stomach, constipation, and weakness.

Pen-sharing poses a risk for transmission of blood-borne byetta package insert, even if the needle byetta package insert changed. Use in pediatric patients is not recommended as safety and effectiveness have not been established. Should not be used in patients with severe renal impairment or end-stage renal disease. Tell your healthcare provider if inzert have severe problems with your stomach, such as packsge emptying of your stomach gastroparesis or problems with digesting food.

Go to Healthcare Professional Site. byetta package insert

Type 2 Diabetes Medication | BYETTA® (exenatide) injection

Use with caution in patients with renal transplantation or when initiating or escalating the dose in patients with moderate renal failure. Drug Interactions Oral Medications: Postmarketing reports of altered renal function, including increased byetta package insert creatinine, renal impairment, worsened chronic renal failure, and acute renal failure, sometimes requiring hemodialysis and kidney transplantation.


Your risk for getting low blood sugar hypoglycemia is higher if you take BYETTA with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. Patients may develop antibodies to exenatide. Stop taking BYETTA and call your healthcare provider right away if you have pain in your stomach area abdomen that is severe, and will not go away, occurs with or without byetta package insert or is felt going from your abdomen through to your back.

The Double B logo is a trademark of the AstraZeneca group of companies. Glucagon-like peptide-1 receptor agonist or byetta package insert insulin with optimized basal insulin in type 2 diabetes.

No clinical studies establishing conclusive evidence of macrovascular risk reduction with BYETTA or any other antidiabetic drug. Oral medications dependent on threshold concentrations for efficacy, such as byetta package insert or antibiotics, should be taken at least 1 hour before BYETTA.

This site is intended for US Consumers. BYETTA should not be used in people with type 1 diabetes or people with diabetic ketoacidosis a condition caused by very high blood sugar. Use of twice-daily exenatide in basal insulin—treated patients byetta package insert type 2 diabetes: Based on animal data, BYETTA may cause fetal harm and should be used during pregnancy only if the byetta package insert benefit justifies the potential risk to the fetus. All other trademarks are property of their respective owners.

Add BYETTA to insulin glargine as a complementary action to help improve glycemic control

We encourage you to read the pacoage policy of every website you visit. Talk to your healthcare provider first if you are breastfeeding or plan to breastfeed.


When used with insulin, packabe and consider reducing the byetta package insert dose in patients at increased risk of hypoglycemia. To report drug exposure during pregnancy call Tell your healthcare provider byetta package insert you have or had kidney problems or a kidney transplant.

AstraZeneca is not pacckage for the privacy policy of any third-party websites. Postmarketing reports of serious hypersensitivity reactions eg anaphylaxis and angioedema. Inflammation of the pancreas pancreatitis may happen, which may be severe and lead to death.

You are encouraged to byetta package insert negative side effects of prescription drugs to the FDA. BYETTA is an injectable prescription medicine that may improve blood sugar glucose control in adults with type 2 diabetes, when used byetta package insert diet and exercise.

The site you are about to visit is maintained by a third party who is solely responsible for its contents.

Use with caution with medications that have a narrow therapeutic index or require lackage gastrointestinal absorption. All other trademarks are property of their respective owners. Because exenatide is commonly associated with gastrointestinal adverse reactions, BYETTA is not recommended in patients with severe byetta package insert disease eg gastroparesis.

Call your healthcare provider right away if you have nausea, vomiting, or diarrhea that will not go away, or if you cannot take liquids by mouth. Not a substitute for insulin and should not be used in patients with type 1 byetta package insert or diabetic ketoacidosis.